Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 48 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 7989501

    Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  2. US 7964559

    MVL, an antiviral protein from a cyanobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  3. US 7939639

    Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2011 · Expires May 5, 2031

    granted

  4. US 7928079

    Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  5. US 7928096

    Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  6. US 7919301

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  7. US 7915036

    Compositions comprising T cell receptors and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  8. US 7842798

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  9. US 7785565

    Metal chelators and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted

  10. US 7641909

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  11. US 7619057

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted

  12. US 7511032

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  13. US 7504430

    Maleiimide anti-tumor phosphatase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  14. US 7501501

    MHC-Class II restricted melanoma antigens and their use in therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  15. US 7498336

    Deazaflavin compounds and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted

  16. US 7459536

    HGF-SF monoclonal antibody combinations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  17. US 7456222

    Anti tubercular drug: compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

  18. US 7427671

    Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and method of making

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted

  19. US 7417136

    Nucleic acid vaccines for prevention of flavivirus infection

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted

  20. US 7341726

    Modified HCV peptide immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted

  21. US 7319091

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted

  22. US 7244558

    Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted

  23. US 7232671

    Pertussis toxin gene: cloning and expression of protective antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2007 · Expires Jun 14, 2027

    granted

  24. US 7226602

    Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 5, 2007 · Expires May 31, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.